15+ Years Experience 6,000+ IVF Successes 70%+ Success Rate Book Free Consultation Today 15+ Years Experience 6,000+ IVF Successes 70%+ Success Rate Book Free Consultation Today
Advanced PGS & PGD Genetic Testing

PGS & PGD Genetic Testing (PGT-A / PGT-M) in Ahmedabad

Looking Beyond the Microscope — Transferring Chromosomally Verified Embryos
Director & Chief Fertility Consultant, Wellspring IVF | 15+ Years Experience
✓ Medically reviewed by Dr. Pranay Shah, MS (ObGy)

Book an Appointment


    Your information is completely safe and confidential

    There is a heartbreaking reality in IVF that no one prepares couples for. A Grade AA blastocyst — the highest embryology grade — is carefully transferred into a perfectly prepared uterus. The embryologist says, ‘This one looks excellent.’ And yet, the cycle fails. Or worse, a pregnancy begins and ends in an early miscarriage.

    The question couples ask — ‘Why? What went wrong?’ — often has a single, invisible answer: the chromosome count inside that perfect-looking embryo was abnormal.

    A microscope can assess what an embryo looks like. It cannot assess what an embryo contains at the chromosomal level. An embryo with Trisomy 21 will grade identically to a chromosomally normal one under conventional morphological grading.

    This is the gap that Preimplantation Genetic Testing (PGT) was designed to bridge.
    At Wellspring IVF, Dr. Pranay Shah uses Next-Generation Sequencing (NGS) to screen all 46 chromosomes before transfer — ensuring every embryo we transfer is biologically verified to have the highest chance of a healthy pregnancy.
    In my 15 years of practice, I have seen patients come after 3 or 4 failed transfers elsewhere — each time with what looked like a perfect embryo. When we perform PGT-A and discover that 60% of their embryos were aneuploid, the picture becomes clear. We are not dealing with implantation failure; we are dealing with a genetic selection problem. PGT-A is not for every patient — but for the right patient, it changes everything."
    Dr. Pranay Shah, Director & Chief Fertility Consultant, Wellspring IVF & Women's Hospital

    PGT-A vs PGT-M — Understanding the Difference

    The term ‘Preimplantation Genetic Testing’ covers two different tests addressing two different clinical problems:

    PGT-A (Formerly: PGS)

    Full name: Preimplantation Genetic Testing for Aneuploidies

    What it tests: All 46 chromosomes via NGS. Identifies euploid (normal) vs aneuploid (abnormal) embryos.

    Who it is for: Women aged 35+, recurrent IVF failure, recurrent miscarriage, high sperm DNA fragmentation, prior chromosomally abnormal pregnancy.

    Primary benefit: Transfer only chromosomally verified embryos — reducing miscarriage and improving live birth rates per transfer.

    PGT-M (Formerly: PGD)

    Full name: Preimplantation Genetic Testing for Monogenic Diseases

    What it tests: A specific, pre-identified gene mutation. A custom genetic probe must be designed before the IVF cycle begins.

    Who it is for: Carriers of Thalassemia, SMA, Sickle Cell, Huntington’s, BRCA1/2, Cystic Fibrosis, Fragile-X.

    Primary benefit: Prevents transmission of known serious genetic disease to the child. Regulated under PCPNDT Act 1994.

    PGT-A vs PGT-M — Quick Comparison

    Feature PGT-A (PGS) PGT-M (PGD)
    What it tests Chromosome number — all 46 screened Specific inherited gene mutation
    Technology Next-Generation Sequencing (NGS) Custom PCR + NGS probe design
    Who it is for Advanced age, recurrent failure, recurrent miscarriage Carriers of known hereditary conditions
    Pre-cycle preparation Minimal — standard IVF workup Extensive — custom probe design (4–8 weeks)
    Biopsy timing Day 5 Blastocyst trophectoderm biopsy Day 5 Blastocyst trophectoderm biopsy
    Requires freeze-all? Yes — results take 10–21 days Yes — mandatory FET cycle
    Sex selection? ILLEGAL — PCPNDT Act 1994 ILLEGAL — PCPNDT Act 1994
    Primary benefit Reduces failed transfers and miscarriage Prevents child inheriting genetic disease

    Understanding IUI Treatment

    Learn from our experts and get inspired by real patient journeys

    Fresh vs. Frozen Embryo Transfer: Which Has Higher Success?
    Fresh vs. Frozen Embryo Transfer: Which Has Higher Success?
    Fresh vs. Frozen Embryo Transfer: Which Has Higher Success?
    Fresh vs. Frozen Embryo Transfer: Which Has Higher Success?
    Browse All Videos

    Who Should Consider PGT Testing?

    PGT is not recommended for every IVF patient. Dr. Pranay Shah evaluates each couple's complete clinical history before advising PGT. The following profiles have strong evidence-based indications:

    1Women of Advanced Maternal Age (35 years and above)

    Egg quality declines significantly with age. By age 40, more than 60% of embryos may carry chromosomal abnormalities. PGT-A identifies the viable embryos within the cohort — saving time, cycles, and emotional resources.

    2 Recurrent IVF Failure (2 or more failed transfers)

    When morphologically good embryos repeatedly fail to implant, chromosomal abnormality is a primary undiagnosed cause. PGT-A determines whether the problem is genetic — before investing in another complete cycle.

    3 Recurrent Pregnancy Loss (2 or more miscarriages)

    Approximately 50–60% of first-trimester miscarriages result from chromosomal aneuploidy. PGT-A dramatically reduces recurrence risk by ensuring only euploid embryos are transferred.

    4 Previous Chromosomally Abnormal Pregnancy

    A prior pregnancy with Down Syndrome (Trisomy 21), Edwards Syndrome, Patau Syndrome, or other chromosomal conditions indicates elevated risk. PGT-A substantially reduces recurrence probability.

    5 Severe Male Factor / High Sperm DNA Fragmentation

    Significant sperm DNA damage (high DFI score) is associated with higher rates of chromosomal errors in embryos after fertilisation. PGT-A provides an additional verification layer.

    6 Carriers of a Hereditary Genetic Disease (PGT-M)

    Couples with confirmed Thalassemia, Sickle Cell, SMA, Huntington’s Disease, BRCA mutations, or other single-gene disorders should discuss PGT-M with Dr. Shah to prevent disease transmission.

    Important Note: PGT does not improve egg quality or create better embryos. Its purpose is accurate selection — identifying the embryo with the highest biological probability of a healthy live birth from the embryos already available. Dr. Pranay Shah will only advise PGT when it is clinically appropriate.

    How PGT-A Works — Step-by-Step at Wellspring IVF

    PGT-A requires precise coordination between the IVF cycle, the embryology laboratory, and the genetic testing facility:

    Step 1 — Pre-Cycle Genetic Counselling

    Dr. Pranay Shah reviews your complete clinical history — age, previous IVF outcomes, miscarriage history, family genetic conditions. He confirms whether PGT-A or PGT-M is indicated and discusses realistic expectations, transparent costs, and the requirement for a freeze-all cycle.

    Step 2 — IVF Stimulation and Egg Retrieval

    A standard controlled ovarian stimulation protocol is followed. The goal is to retrieve an adequate number of mature eggs. Having multiple embryos is advantageous — a larger cohort increases the probability of finding at least one euploid embryo.

    Step 3 — Fertilisation via ICSI and Blastocyst Culture

    Eggs are fertilised using ICSI (Intracytoplasmic Sperm Injection). Embryos are cultured to the blastocyst stage (Day 5 or Day 6). Only blastocysts of adequate quality proceed to biopsy. Day 3 biopsy has been largely abandoned globally.

    Step 4 — Trophectoderm Biopsy (Critical Step)

    The embryologist uses a precision laser-assisted system to remove 4–6 cells from the trophectoderm — the outer layer that becomes the placenta. The inner cell mass (which forms the baby) is completely undisturbed. This procedure is safe and validated across thousands of cycles globally.

    Step 5 — Freeze-All: Embryo Vitrification

    Immediately after biopsy, all embryos are vitrified (flash-frozen). A fresh transfer is not possible — genetic results take 10–21 days. All embryos are stored safely until results are received.

    Step 6 — Next-Generation Sequencing (NGS) Analysis

    Biopsied cells are analysed at our partnered NABL-accredited genetics laboratory. NGS screens all 24 chromosome types, categorising each embryo as: Euploid (normal — suitable for transfer) | Aneuploid (abnormal — not suitable) | Mosaic (mixed — requires counselling).

    Step 7 — Frozen Embryo Transfer of Verified Euploid Embryo

    Once results are received, Dr. Pranay Shah personally consults the couple. In the next prepared Frozen Embryo Transfer (FET) cycle, the highest-quality euploid embryo is carefully thawed and transferred under ultrasound guidance.

    Why Day 5 Biopsy — Not Day 3?

    At Day 3, an embryo has only 8 cells — removing one removes 12.5% of its mass. At Day 5, the trophectoderm has 100–200 cells; removing 5–6 causes negligible disruption and produces far more accurate genomic data. Day 3 biopsy has been largely abandoned globally.

    What Is a Mosaic Embryo?

    A mosaic embryo contains a mixture of euploid and aneuploid cells. Some mosaic embryos self-correct and result in healthy pregnancies. Management of mosaics is nuanced — Dr. Shah provides personalised counselling based on mosaicism level and type.
    ★★★★★ 4.9/5.0

    What Our Patients Say

    Real stories from real families who trusted us with their fertility journey
    500+ Google Reviews  •  Verified Patient Testimonials

    Join 500+ Satisfied Families

    Read all our verified Google reviews or share your own experience

    Genetic Diseases Detected by PGT-M (PGD)

    PGT-M can be designed for virtually any known single-gene disorder, provided the specific mutation is identified in advance by a clinical geneticist:
    Genetic Condition Inheritance Relevance for Gujarat / India
    Beta-Thalassemia Major Autosomal Recessive One of the most prevalent inherited blood disorders in Gujarat. Carrier couples face a 25% risk of a severely affected child per pregnancy.
    Sickle Cell Disease Autosomal Recessive HBB gene mutation. High carrier frequency in tribal and certain communities across Gujarat.
    Who it is for Advanced age, recurrent failure, recurrent miscarriage Carriers of known hereditary conditions
    Pre-cycle preparation Minimal — standard IVF workup Extensive — custom probe design (4–8 weeks)
    Biopsy timing Day 5 Blastocyst trophectoderm biopsy Day 5 Blastocyst trophectoderm biopsy
    Requires freeze-all? Yes — results take 10–21 days Yes — mandatory FET cycle
    Sex selection? ILLEGAL — PCPNDT Act 1994 ILLEGAL — PCPNDT Act 1994
    Primary benefit Reduces failed transfers and miscarriage Prevents child inheriting genetic disease
    Fragile-X Syndrome X-Linked FMR1 gene CGG expansion — leading genetic cause of intellectual disability. PGT-M prevents transmission.
    Duchenne Muscular Dystrophy X-Linked Recessive DMD gene mutation. Carrier mothers can use PGT-M to select unaffected embryos for transfer.

    Is PGS/PGD the Right Step for You?

    Understand how genetic testing can support a healthier IVF outcome. Get a thorough evaluation of your medical and fertility history Receive honest advice on whether PGS/PGD is truly needed Consult Dr Pranay Shah for personalized guidance and next steps.

    Does PGT-A Actually Improve Outcomes? — Evidence-Based Analysis

    The evidence supporting PGT-A is strongest in specific patient populations. An honest, clinically grounded comparison:

    Patient Profile

    Aneuploidy Rate Without PGT

    Benefit of PGT-A

    Dr. Shah’s Recommendation

    Women aged 35–37

    40–50% of embryos aneuploid

    Identifies euploid embryos; faster time-to-pregnancy

    Recommended

    Women aged 38–40

    55–65% of embryos aneuploid

    Identifies the viable minority in the cohort

    Strongly Recommended

    Women aged 41 and above

    70–80% of embryos aneuploid

    Critical selection; informs donor egg decision

    Strongly Recommended

    Recurrent implantation failure

    Chromosomal cause often undetected

    Reveals if genetics is the root cause

    Strongly Recommended

    Recurrent miscarriage

    High aneuploidy rate in embryos

    Euploid transfer: 10–15% vs 25–40% miscarriage rate

    Strongly Recommended

    Women under 35, first cycle, good response

    20–30% of embryos aneuploid

    Marginal benefit; many euploid embryos naturally available

    Not routinely recommended

    Frequently Asked Questions

    Common questions about PGT-A, PGT-M, embryo biopsy, cost, and legal restrictions in India.
    Ask a Question
    Complete Information Map

    IVF Treatment — Related Pages & Sub-Treatments

    Ensure all links below are live before publishing. These cross-links strengthen the Treatments Silo and pass authority between related pages:

    Related Insights & Articles

    Start Your Parenthood Journey Today

    Expert care, proven results, and compassionate support every step of the way